Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001654706-15-000002
Filing Date
2015-10-02
Accepted
2015-10-02 13:33:05
Documents
1
Effectiveness Date
2015-10-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9860
  Complete submission text file 0001654706-15-000002.txt   10935
Mailing Address 4320 FOREST PARK AVENUE SUITE 303 ST. LOUIS MO 63108
Business Address 4320 FOREST PARK AVENUE SUITE 303 ST. LOUIS MO 63108 314-882-6886
Antegrin Therapeutics, Inc. (Filer) CIK: 0001654706 (see all company filings)

EIN.: 473395909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-248659 | Film No.: 151139517